Cross ntry Healthcare(CCRN) - 2025 Q1 - Quarterly Results

Exhibit 99.1 | | | | | Variance | | Variance | | --- | --- | --- | --- | --- | --- | --- | | | | | | Q1 2025 vs | | Q1 2025 vs | | Dollars are in thousands, except per share amounts | | Q1 2025 | | Q1 2024 | | Q4 2024 | | Revenue | $| 293,408 | | (23) % | | (5) % | | Gross profit margin* | | 20.0 % | | (40) bps | | — bps | | Net loss attributable to common stockholders |$ | (490) | | (118) % | | 87 % | | Diluted EPS | $| (0.02) |$ | (0.10) | $| 0.10 | | Adjusted EBITDA* |$ | 8,619 | | (44) % | | (7) % ...